I M E Wentholt
Overview
Explore the profile of I M E Wentholt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wentholt I, Bras J, Kroon F, van Dijkum E, Fliers E
Neth J Med
. 2012 Aug;
70(6):292-3.
PMID: 22859425
No abstract available.
2.
Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan C, et al.
Diabet Med
. 2011 Feb;
28(10):1158-67.
PMID: 21294770
Aims: To investigate the efficacy of sensor-augmented pump therapy vs. multiple daily injection therapy in patients with suboptimally controlled Type 1 diabetes. Methods: In this investigator-initiated multi-centre trial (the Eurythmics...
3.
Wentholt I, Hart A, Hoekstra J, DeVries J
Diabetes Technol Ther
. 2008 Feb;
10(2):57-68.
PMID: 18260769
Continuous glucose monitors may be valuable tools for improving glycemic control and avoiding hypoglycemia in patients with diabetes. To this goal, sensor readings must adequately reflect the actual blood glucose,...
4.
Wentholt I, Kulik W, Michels R, Hoekstra J, DeVries J
Diabetologia
. 2007 Nov;
51(1):183-90.
PMID: 17994218
Aims/hypothesis: Glucose fluctuations may help predict diabetic complications. We evaluated the relation between glucose variability and oxidative stress in patients with type 1 diabetes. Methods: Continuous glucose monitors were inserted...
5.
Wentholt I, Hoekstra J, DeVries J
Diabetes Technol Ther
. 2007 Oct;
9(5):399-409.
PMID: 17931048
To date, several continuous glucose sensors have been developed and launched in the U.S. and European markets, though large-scale application in standard diabetes care still awaits its breakthrough. This report...
6.
Wentholt I, Maran A, Masurel N, Heine R, Hoekstra J, DeVries J
Diabet Med
. 2007 Mar;
24(5):527-32.
PMID: 17381503
Aims: We quantified the occurrence and duration of nocturnal hypoglycaemia in individuals with Type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) or multiple-injection therapy (MIT) using a continuous...
7.
Wentholt I, Hoekstra J, Zwart A, DeVries J
Diabetologia
. 2005 May;
48(6):1055-8.
PMID: 15871008
The development of a truly non-invasive continuous glucose sensor is an elusive goal. We describe the rise and fall of the Pendra device. In 2000 the company Pendragon Medical introduced...